Ординатура / Офтальмология / Английские материалы / Handbook of Pediatric Neuro-Ophthalmology_Wright, Spiegel, Thompson_2006

40.Folz SJ, Trobe JD. The peroxisome and the eye. Surv Ophthalmol 1991;35(5):353–368.

41.Galvin JE, Giasson B, et al. Neurodegeneration with brain iron accumulation, type 1 is characterized by alpha-, beta-, and gammasynuclein neuropathology. Am J Pathol 2000;157(2):361–368.

42.Garbern J, Cambi F, et al. The molecular pathogenesis of Pelizaeus– Merzbacher disease. Arch Neurol 1999;56(10):1210–1214.

43.Gardiner RM. Mapping the gene for juvenile onset neuronal ceroid lipofuscinosis to chromosome 16 by linkage analysis. Am J Med Genet 1992;42:539–541.

44.Gascon GG, Yamani S, Cafege A, et al. Treatment of subacute sclerosing panencephalitis with alpha interferon. Ann Neurol 1991;30: 227–228.

45.Gencic S, Abuelo D, Ambler M, Hudson LD. Pelizaeus–Merzbacher disease: an X-linked neurologic disorder of myelin metabolism with a novel mutation in the gene encoding proteolipid protein. Am J Hum Genet 1989;45:435–442.

46.Gieselmann V, von Figura K. Advances in molecular genetics of metachromatic leukodystrophy. J Inherit Metab Dis 1990;13:560– 571.

47.Gieselmann V, Matzner U, et al. Metachromatic leukodystrophy: molecular genetics and an animal model. J Inherit Metab Dis 1998; 21(5):564–574.

48.Glasgow BJ, Brown HH, et al. Ocular pathologic findings in neonatal adrenoleukodystrophy. Ophthalmology 1987;94(8):1054–1060.

49.Goebel HH, Schochet SS, et al. Progress in neuropathology of the neuronal ceroid lipofuscinoses. Mol Genet Metab 1999;66(4):367–372.

50.Goldberg MF, Payne JW, Brunt SPW. Ophthalmologic studies of familial dysautonomia. Arch Ophthalmol 1968;80:732–743.

51.Goto Y, Nonaka I, Horai S, et al. A mutation in the tRNA(Leu) (UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies. Nature (Lond) 1990;348(6302):651–653.

52.Gould SJ, Valle D. Peroxisome biogenesis disorders: genetics and cell biology. Trends Genet 2000;16(8):340–345.

53.Greenberg SB, Faerber EN, Riviello JJ, et al. Subacute necrotizing encephalomyelopathy (Leigh disease): CT and MRI appearances. Pediatr Radiol 1990;21(1):5–8.

54.Greenfield J. Encephalitis and encephalomyelitis in England and Wales during the last decade. Brain 1950;73:141.

55.Hagenfeldt L, Bollgren I, Venizelos N, et al. N-Acetylaspartic aciduria due to aspartoacylase deficiency—a new aetiology of childhood leukodystrophy. J Inherit Metab Dis 1987;10(2):135–141.

56.Hanna MG, Nelson IP, et al. MELAS: a new disease associated mitochondrial DNA mutation and evidence for further genetic heterogeneity. J Neurol Neurosurg Psychiatry 1998;65(4):512–517.

57.Harari D, Gibberd FB, Dick JPR, et al. Plasma exchange in the treatment of Refsum’s disease (heredopathia atactica polyneuritiformis). J Neurol Neurosurg Psychiatry 1991;54(7):614–617.

362HANDBOOK OF PEDIATRIC NEURO-OPHTHALMOLOGY

58.Harzer K, Schuster I. Prenatal enzymatic diagnosis of Krabbe disease (globoid-cell leukodystrophy) using chorionic villi. Pitfalls in the use of uncultured villi. Hum Genet 1989;84(1):83–85.

59.Herz B, Bach G. Arylsulfatase A in pseudodeficiency. Hum Genet 1984;66(2–3):147–150.

60.Hofman KJ, Naidu S, Moser HW, Maumenee IH, Wenger DA. Cherry red spot in association with galactosylceramide-beta-galac- tosidase deficiency. J Inherit Metab Dis 1987;10:273–274.

61.Holt IJ, Harding AE, Petty RKH, et al. A new mitochondrial disease associated with mitochondrial DNA heteroplasmy. Am J Hum Genet 1990;46:428–433.

62.Hoogerbrugge PM, Poorthuis BJHM, Romme AE, van de Kamp JJP, Wagemaker G, van Bekhum PW. Effect of bone marrow transplantation on enzyme levels and clinical course in the neurologically affected twitcher mouse. J Clin Invest 1988;81:1790– 1794.

63.Horta-Barbosa L, Fuccillo DA, Sever JL, Zeman W. Subacute sclerosing pancephalitis: isolation of measles from brain biopsy. Nature (Lond) 1969;221:974.

64.Howell N. Leber hereditary optic neuropathy: mitochondrial mutations and degeneration of the optic nerve. Vision Res 1997;37(24): 3495–3507.

65.Hudson LD, Puckett C, Berndt J, Chan J, Gencic S. Mutation of the proteolipid protein gene PLP in a human X chromosome-linked myelin disorder. Proc Natl Acad Sci USA 1989;86:8128–8131.

66.Inui K, Kao FT, et al. The gene coding for a sphingolipid activator protein, SAP-1, is on human chromosome 10. Hum Genet 1985; 69(3):197–200.

67.Jankovic J, Kirkpatrick JB, Blomquist KA, et al. Late-onset Haller- vorden–Spatz disease presenting as familial parkinsonism. Neurology 1985;35(2):227–234.

68.Järvelä I, Vesa J, Santavuori P, Hellsten E, Peltonen L. Molecular genetics of neuronal ceroid lipofuscinoses. Pediatr Res 1992;32: 645–648.

69.Janin N, Andrieu N, et al. Breast cancer risk in ataxia-telangiecta- sia (AT) heterozygotes: haplotype study in French AT families. Br J Cancer 1999;80:1042–1045.

70.Kappler J, Leinekugel P, Conzelmann E, et al. Genotype-phenotype relationship in various degrees of arylsulfatase A deficiency. Hum Genet 1991;86:463–470.

71.Kaye EM. Update on genetic disorders affecting white matter. Pediatr Neurol 2001;24(1):11–24.

72.Kelley RI, Datta NS, Dobyns WB, et al. Neonatal adrenoleukodystrophy: new cases, biochemical studies, and differentiation from Zellweger and related peroxisomal polydystrophy syndromes. Am

J Med Genet 1986;23:869–901.

74.Kelley RI, Moser HW. Hyperpipecolic acidemia in neonatal adrenoleukodystrophy. Am J Med Genet 1984;19:791–795.

75.Kimura S, Ohtuki N, et al. Clinical and radiologic improvements in mitochondrial encephalomyelopathy following sodium dichloroacetate therapy. Brain Dev 1997;19(8):535–540.

76.Kimura S, Kobayashi T, Amemiya F, et al. Myelin splitting in the spongy lesion in Leigh encephalopathy. Pediatr Neurol 1991;7(1): 56–58.

77.Kobayashi M, Morishita H, Sugiyama N, et al. Two cases of NADHcoenzyme Q reductase deficiency: relationship to MELAS syndrome. J Pediatr 1987;110:223.

78.Koeppen AH. The hereditary ataxias. J Neuropathol Exp Neurol 1998;57(6):531–543.

79.Koeppen AH, Ronca NA, Greenfield EA, et al. Defective biosynthesis of proteolipid protein in Pelizaeus–Merzbacher disease. Ann Neurol 1987;21(2):159–170.

80.Kolodny EL. Sulfatide lipidosis: metachromatic leukodystrophy. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic basis of inherited diseases. New York: McGraw-Hill, 1989:1721–1749.

81.Kolodny EH, Cable WJ. Inborn errors of metabolism. Ann Neurol 1982;11(3):221–232.

82.Korczyn AD, Rubenstein AE, Yahr MD, Axelrod FB. The pupil in familial dysautonomia. Neurology 1981;31:628.

83.Krivit W, Shapiro E, Kennedy W, et al. Treatment of late infantile metachromatic leukodystrophy by bone marrow transplantation. N Engl J Med 1990;322:28–31.

84.Krivit W, Peters C, et al. Bone marrow transplantation as effective treatment of central nervous system disease in globoid cell leukodystrophy, metachromatic leukodystrophy, adreno-leukodystrophy, mannosidosis, fucosidosis, aspartylglucosaminuria, Hurler, Maroteaux–Lamy, and Sly syndromes, and Gaucher disease type III. Curr Opin Neurol 1999;12(2):167–176.

85.Kurokawa T, Chen YJ, Nagates M, et al. Late infantile Krabbe leukodystrophy: MRI and evoked potentials in a Japanese girl. Neuropediatrics 1987;18(3):182–183.

86.Lake BD, Young EP, et al. Prenatal diagnosis of lysosomal storage diseases. Brain Pathol 1998;8(1):133–149.

87.Lane SC, Jolly RD, et al. Apoptosis as the mechanism of neurodegeneration in Batten’s disease. J Neurochem 1996;67(2):677–683.

88.Lazo O, Contreras M, Hashnil M, Stanley W, Irazu C, Singh T. Peroxisomal lignoceroyl-CoA ligase deficiency in childhood adrenoleukodystrophy and adrenoneuropathy. Proc Natl Acad Sci USA 1988;85:7647–7651.

89.Learish RD, Brustle O, et al. Intraventricular transplantation of oligodendrocyte progenitors into a fetal myelin mutant results in widespread formation of myelin. Ann Neurol 1999;46(5):716–722.

90.Leigh D. Subacute necrotizing encephalomyelopathy in an infant. J Neurol Neurosurg Psychiatry 1951;14:216–221.

91.Li A, Swift M. Mutations at the ataxia-telangiectasia locus and clinical phenotypes of A-T patients. Am J Med Genet 2000;92:170–177.

364HANDBOOK OF PEDIATRIC NEURO-OPHTHALMOLOGY

92.Loonen MC, Van Diggelen OP, Janse HC, et al. Late-onset globoid cell leucodystrophy (Krabbe’s disease). Clinical and genetic delineation of two forms and their relation to the early-infantile form. Neuropediatrics 1985;16(3):137–142.

93.Luckenbach MW, Green WR, Miller NR, Moser WH, Clark AW, Tennekoon G. Ocular clinicopathologic correlation of Hallervorden– Spatz syndrome with acanthocytosis and pigmentary retinopathy. Am J Ophthalmol 1983;95:369–382.

94.MacCollin M, De Vivo CD, et al. Ataxia and peripheral neuropathy: a benign variant of peroxisome dysgenesis. Ann Neurol 1990;28(6):833–836.

95.Manz HJ, Schvelein M, McCullough DC, Kishimoto Y, Eiben RM. New phenotypic variant of adrenoleukodystrophy: pathologic, ultrastructural, and biochemical study in two brothers. J Neurol Sci 1980;45:245–260.

96.Matalon R, Kaul R, Casanova J, et al. Aspartoacylase deficiency: the enzyme defect in Canavan disease. J Inherit Metab Dis 1989; 12(suppl 2):329–331.

97.Matalon R, Michals-Matalon K. Prenatal diagnosis of Canavan disease. Prenat Diagn 1999;19(7):669–670.

98.Matalon R, Michals-Matalon K. Recent advances in Canavan disease. Adv Pediatr 1999;46:493–506.

99.Matsuura T, Yamagata T, et al. Large expansion of the ATTCT pentanucleotide repeat in spinocerebellar ataxia type 10. Nat Genet 2000;26(2):191–194.

100.Mattei MG, Alliel PM, Dautigny A, et al. The gene encoding for the major brain proteolipid (PLP) maps on the q-22 band of the human X chromosome. Hum Genet 1986;72:352–353.

101.McFarlin DE, Strober W, Barlow M, et al. The immunological deficiency state in ataxia-telangiectasia. Res Publ Assoc Res Nerv Ment Dis 1971;49:275.

102.Miyazaki M, Hashimoto T, Fujino K, Goda T, Tayama M, Kuroda Y. Apparent response of subacute sclerosing pancephalitis to intrathecal interferon alpha. Ann Neurol 1991;29:97–99.

103.Morgan-Hughes JA, Hanna MG. Mitochondrial encephalomyopathies: the enigma of genotype versus phenotype. Biochim Biophys Acta 1999;1410(2):125–145.

104.Moser HW, Moser AB, Frayer KK, et al. Adrenoleukodystrophy: increased plasma content of saturated very long chain fatty acids. Neurology 1981;31:1241–1249.

105.Moser AB, Moser HW. The prenatal diagnosis of X-linked adrenoleukodystrophy. Prenat Diagn 1999;19(1):46–48.

106.Moser HW. The peroxisome: nervous system role of a previously underrated organelle. The 1987 Robert Wartenberg lecture. Neurology 1988;38(10):1617–1627.

107.Moser HW. Adrenoleukodystrophy: phenotype, genetics, pathogenesis and therapy. Brain 1997;120(pt 8):1485–1508.

108.Moser HW. Genotype-phenotype correlations in disorders of peroxisome biogenesis. Mol Genet Metab 1999;68(2):316–327.

109.Moser HW. Molecular genetics of peroxisomal disorders. Front Biosci 2000;5:D298–D306.

110.Moser HW, Kemp S, et al. Mutational analysis and the pathogenesis of variant X-linked adrenoleukodystrophy phenotypes. Arch Neurol 1999;56(3):273–275.

111.Moser H, Smith K, et al. X-linked adrenoleukodystrophy. In: Scriver C, Kinzler K, Vogelstein B, et al. (eds) The metabolic and molecular bases of inherited disease. New York: McGraw-Hill, 2000: 3257–3301.

112.Munoz A, Mateos F, et al. Mitochondrial diseases in children: neuroradiological and clinical features in 17 patients. Neuroradiology 1999;41(12):920–928.

113.Nadal N, Rolland MO, et al. Localization of Refsum disease with increased pipecolic acidaemia to chromosome 10p by homozygosity mapping and carrier testing in a single nuclear family. Hum Mol Genet 1995;4(10):1963–1969.

114.Nagashima K, Suzuki S, Ichikawa E, et al. Infantile neuroaxonal dystrophy: perinatal onset with symptoms of diencephalic syndrome. Neurology 1985;35(5):735–738.

115.Naidu S, Hofmann KJ, et al. Galactosylceramide-beta-galactosidase deficiency in association with cherry red spot. Neuropediatrics 1988;19(1):46–48.

116.Nardocci N, Zorzi G, et al. Infantile neuroaxonal dystrophy: clinical spectrum and diagnostic criteria. Neurology 1999;52(7):1472– 1478.

117.Neumann M, Adler S, et al. Alpha-synuclein accumulation in a case of neurodegeneration with brain iron accumulation type 1 (NBIA-1, formerly Hallervorden–Spatz syndrome) with widespread cortical and brainstem-type Lewy bodies. Acta Neuropathol (Berl) 2000;100(5):568–574.

118.Newell FW, Johnson RO, Huttenlocker PR. Pigmentary degeneration of the retina in the Hallervorden–Spatz syndrome. Am J Ophthalmol 1979;88:467–471.

119.Nishizawa M, Tanaka K, Shinozawa K, et al. A mitochondrial encephalomyopathy with cardiomyopathy: a case revealing a defect of complex I in the respiratory chain. J Neurol Sci 1987;78:189.

120.Ohama E, Ohara S, Ikuta F, et al. Mitochondrial angiopathy in cerebral blood vessels of mitochondrial encephalomyopathy. Acta Neuropathol (Berl) 1987;74:226.

121.Ohyagi Y, Yamada T, et al. Vergence disorders in patients with spinocerebellar ataxia 3/Machado–Joseph disease: a synoptophore study. J Neurol Sci 2000;173(2):120–123.

122.Ortiz R, Newman NJ, Shoffner JM, et al. Variable retinal and neurologic manifestations in patients harboring the mitochondrial DNA 8993 mutation. Arch Ophthalmol 1993;111:1525–1530.

366HANDBOOK OF PEDIATRIC NEURO-OPHTHALMOLOGY

123.Ozand PT, Gascon GG, Al Ageel A, et al. Prenatal detection of Canavan disease. Lancet 1991;337:735–736.

124.Pearson JF, Finegold MJ, Budzilovich G. The tongue and taste in familial dysautonomia. Pediatrics 1970;45:739–745.

125.Peltonen L, Savukoski M, et al. Genetics of the neuronal ceroid lipofuscinoses. Curr Opin Genet Dev 2000;10(3):299–305.

126.Pham-Dinh D, Popot JL, Boespflug-Tanguy O, et al. Pelizaeus– Merzbacher disease: a valine to phenylalanine point mutation in a putative extracellular loop of myelin proteolipid. Proc Natl Acad Sci USA 1991;88(17):7562–7566.

127.Poll-The BT, Roels F, Ogien H, et al. A new peroxisomal disorder with enlarged peroxisomes and a specific deficiency of acyl-Co-A oxidase (pseudo-neonatal adrenoleukodystrophy). Am J Hum Genet 1988;42:422–434.

128.Poll-The BT, Saudubray JM, Ogier H, et al. Infantile Refsum’s disease: biochemical findings suggesting multiple peroxisomal dysfunction. J Inherit Metab Dis 1986;9(2):169–174.

129.Polten A, Fluharty AL, Fluharty CB, von Figura K, Gieselmann V. Molecular basis of different forms of metachromatic leukodystrophy. N Engl J Med 1991;324:18–22.

130.Poser CM. Notes on pathogenesis of subacute sclerosing panencephalitis. J Neurol Sci 1990;95:219–224.

131.Poulton J, Marchington DR. Progress in genetic counselling and prenatal diagnosis of maternally inherited mtDNA diseases. Neuromusc Disord 2000;10(7):484–487.

132.Powers JM, Schaumburg HH, Johnson AB, et al. A correlative study of the adrenal cortex in adrenoleukodystrophy: evidence for a fatal intoxication with very long chain fatty acids. Investig Cell Pathol 1980;3:353–376.

133.Pratt VM, Trofatter JA, Schinzel A, Dlouhy SR, Conneally PM, Hodes ME. A new mutation in the proteolipid protein (PLP) gene in a German family with Pelizaeus–Merzbacher disease. Am J Med Genet 1991;38:136–139.

134.Refsum S. Heredopathia atactica polyneuritiformis. Acta Psychiatr Scand (Suppl) 1946;38:9.

135.Rider JA, Rider DL. Batten disease: past, present, and future. Am J Med Genet 1988;5(suppl):21–26.

136.Rider JA, Rider DL. Thirty years of Batten disease research: present status and future goals. Mol Genet Metab 1999;66(4):231– 233.

137.Rizzo JF, Lessell S, Liebman SD. Optic atrophy in familial dysautonomia. Am J Ophthalmol 1986;102:463–467.

138.Robb RM, Watters GV. Ophthalmic manifestations of subacute sclerosing panencephalitis. Arch Ophthalmol 1970;83:426– 435.

139.Roberts RM. Prevention of human mitochondrial (mtDNA) disease by nucleus transplantation into an enucleated donor oocyte. Am J Med Genet 1999;87(3):265–266.

140.Roels F, Cornelis A, Poll-The BT, et al. Hepatic peroxisomes are deficient in infantile Refsum disease: a cytochemical study of 4 cases. Am J Med Genet 1986;25:257–271.

141.Roels F, Cornelis A, et al. Hepatic peroxisomes are deficient in infantile Refsum disease: a cytochemical study of 4 cases. Am J Med Genet 1986;25(2):257–271.

142.Rushton AR, Shaywitz BA, Duncan CC, et al. Computed tomography in the diagnosis of Canavan’s disease. Ann Neurol 1981;10(1): 57–60.

143.Sakuta R, Goto Y-I, Horai S, Nonaka I. Mitochondrial DNA mutations at nucleotide positions 3243 and 3271 in mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes: a comparative study. J Neurol Sci 1993;115:158–160.

144.Schaffert DA, Johnsen SD, Johnson PC, Drayer BP. Magnetic resonance imaging in pathologically proven Hallervorden–Spatz disease. Neurology 1989;39:440–442.

145.Scheffer IE, Boraitser M, Wilson J, et al. Pelizaeus–Merzbacher disease: classical or connatal? Neuropediatrics 1991;22(2):71–78.

146.Schelhaas HJ, Ippel PF, et al. Similarities and differences in the phenotype, genotype and pathogenesis of different spino-cerebellar ataxias. Eur J Neurol 2000;7(3):309–314.

147.Schindler D, Bishop DF, Wolfe DE, et al. Neuroaxonal dystrophy due to lysosomal alpha-N-acetylgalactosaminidase deficiency. N Engl J Med 1989;320(26):1735–1740.

148.Schram AW, Strijland A, Hashimoto RJA, Schutgens RBH, van den Bosch H, Tager JM. Biosynthesis and maturation of peroxisomal-oxidation enzymes in fibroblasts in relation to the Zellweger syndrome and infantile Refsum disease. Proc Natl Acad Sci USA 1986;83:6156–6158.

149.Schram AW, Strijland A, et al. Biosynthesis and maturation of peroxisomal beta-oxidation enzymes in fibroblasts in relation to the Zellweger syndrome and infantile Refsum disease. Proc Natl Acad Sci USA 1986;83(16):6156–6158.

150.Schutgens RBH, Schrakamp G, Wanders RJA, Heymans HSA, Tager JM, van den Bosch H. Prenatal and perinatal diagnosis of peroxisomal disorders. J Inherit Metab Dis 1989;12(1):118–134.

151.Scotto JM, Hadchouel M, Odievre M, et al. Infantile phytanic acid storage disease, a possible variant of Refsum’s disease: three cases, including ultrastructural studies of the liver. J Inherit Metab Dis 1982;5:83–90.

152.Seitelberger F. Eine unbekannte form von infantiler lipoidspecherkrankhect des gehirns. Proc First Int Cong Neuropathol, vol 3. Turin: Rosenberg and Sellier, 1952.

153.Seitelberger F. In: Vinken P, Bruyn G (eds) Peliazeus–Merzbacher disease. Leucodystrophies and poliodystrophies, vol 10. Amsterdam: North Holland, 1970:150–201.

154.Seitelberger F. Neuroaxonal dystrophy: its relation to aging and neurologic disease. In: Vinken P, Bruyn G, Klawans H (eds) Hand-

book of clinical neurology, vol 49. Amsterdam: Elsevier, 1986:391– 415.

155.Seitelberger F. Neuropathology and genetics of Pelizaeus– Merzbacher disease. Brain Pathol 1995;5(3):267–273.

156.Shapiro LJ, Aleck KA, Kaback MM, et al. Metachromatic leukodystrophy without arylsulfatase A deficiency. Pediatr Res 1979;13:

1179–1181.

158.Shapiro E, Krivit W, et al. Long-term effect of bone-marrow transplantation for childhood-onset cerebral X-linked adrenoleukodystrophy. Lancet 2000;356(9231):713–718.

159.Shoffner JM, Lott MJ, Lezza AMS, et al. Myoclonic epilepsy and ragged-red fiber disease (MERRF) is associated with a mitochondrial DNA tRNAlys mutation. Cell 1990;61:931–937.

160.Siemerling E, Creutzfeldt HG. Bronzekrankheit und sklerosierende encephalomyelitis. Arch Psychiatr Nervenski 1923;68: 217–244.

161.Simon DK, Johns DR. Mitochondrial disorders: clinical and genetic

features. Annu Rev Med 1999;50:111–127.

161a. Slaugenhaupt SA, Blumenfeld A, Gill SP, et al. Tissue-specific expression of a splicing mutation in the IKBKAP gene causes familial dysautonomia. Am J Hum Genet 2001;68(3):598–605.

162.Smith GC, Cary RB, et al. Purification and DNA binding properties of the ataxia-telangiectasia gene product ATM. Proc Natl Acad Sci USA 1999;96:11134–11139.

163.Steinberg D. Refsum’s disease. In: Scriver CT, et al. (eds) The metabolic basis of inherited disease. New York: McGraw-Hill, 1989: 1533–1550.

164.Steinlin M, Blaser S, et al. Cerebellar involvement in metabolic disorders: a pattern-recognition approach. Neuroradiology 1998;40(6): 347–354.

165.Stevanin G, Durr A, et al. Spinocerebellar ataxia type 7. Handbook of ataxia disorders. New York: Dekker, 2000;50:469–486.

166.Stoffel W, Hillen H, Giersiefen H. Structure and molecular arrangement of proteolipid protein of central nervous system myelin. Proc Natl Acad Sci USA 1984;81:5012–5016.

167.Su Y, Swift M. Mortality rates among carriers of ataxia-telan- giectasia mutant alleles. Ann Intern Med 2000;133:770–778.

168.Swoveland PT. Molecular events in measles virus infection of the central nervous system. Int Rev Exp Pathol 1991;32:355– 375.

169.Topcu M, Saatci I, et al. Leigh syndrome in a 3-year-old boy with unusual brain MR imaging and pathologic findings. AJNR (Am J Neuroradiol) 2000;21(1):224–227.

170.Tourtellotte WW, Ma BI, Brandes DB, Walsh MJ, Potvin AR. Quantification of denovo central nervous system IgG measles antibody synthesis in SSPE. Ann Neurol 1981;9:551–556.

171.Toussaint D, Danis P. An ocular pathologic study of Refsum’s syndrome. Am J Ophthalmol 1971;72(2):342–347.

172.Traboulsi EI, Maumenee IH. Ophthalmologic manifestations of X- linked childhood adrenoleukodystrophy. Ophthalmology 1987; 94(1):47–52.

173.Trobe JD, Sharpe JA, Hirsh DK, et al. Nystagmus of Pelizaeus– Merzbacher disease. A magnetic search-coil study. Arch Neurol 1991;48(1):87–91.

174.Trofatter JA, Dlouhy SR, De Myer W, Conneally PM, Hodes ME. Pelizaeus–Merzbacher disease: tight linkage to proteolipid protein gene axon variant. Proc Natl Acad Sci USA 1989;86:9427– 9430.

175.Udar NS, Xu S, et al. Physical map of the region surrounding the ataxia-telangiectasia gene on human chromosome 11q22-23. Neuropediatrics 1999;30:176–180.

176.Uziel G, Bertini E, Rimoldi M, et al. Experience on therapy of adreno-leukodystrophy and adrenomyeloneuropathy. Dev Neurosci 1991;13(4–5):274–279.

177.Wallace DC, Zheng X, Lott MT, et al. Familial mitochondrial encephalomyopathy (MERRF): genetic, pathophysiological, and biochemical characterization of a mitochondrial DNA disease. Cell 1988;55:601.

178.Wanders RJ, Schutgens RB, et al. Infantile Refsum disease: deficiency of catalase-containing particles (peroxisomes), alkyldihydroxyacetone phosphate synthase and peroxisomal beta-oxidation enzyme proteins. Eur J Pediatr 1986;145(3):172–175.

179.Wang AM, Schindler D, Desnick RJ. Schindler disease: the molecular lesion in the -N-acetylgalactosaminidase gene that causes an infantile neuroaxonal dystrophy. J Clin Investig 1990;86:1752– 1756.

180.Wang AM, Desnick RJ. Structural organization and complete sequence of the human alpha-N-acetylgalactosaminidase gene: homology with the alpha-galactosidase A gene provides evidence for evolution from a common ancestral gene. Genomics 1991;10(1): 133–142.

181.Wang AM, Bishop DF, et al. Human alpha-N-acetylgalac- tosaminidase-molecular cloning, nucleotide sequence, and expression of a full-length cDNA. Homology with human alphagalactosidase A suggests evolution from a common ancestral gene. J Biol Chem 1990;265(35):21859–21866.

182.Weimbs T, Dick T, Stoffel W, Bolthauser E. A point mutation at the X-chromosomal proteolipid protein locus in Pelizaeus– Merzbacher disease leads to disruption of myelinogenesis. Biol Chem Hoppe Seyler 1990;371:1175–1183.

183.Weinberg K, Moser A, Watkins P, et al. Bone marrow transplantation for adrenoleukodystrophy. Pediatr Res 1988;23:334A.

184.Weinstein R. Phytanic acid storage disease (Refsum’s disease): clinical characteristics, pathophysiology and the role of therapeutic apheresis in its management. J Clin Apheresis 1999;14(4):181– 184.

370HANDBOOK OF PEDIATRIC NEURO-OPHTHALMOLOGY

185.Weleber RG. The dystrophic retina in multisystem disorders: the electroretinogram in neuronal ceroid lipofuscinoses. Eye 1998; 12(pt 3b):580–590.

186.Wenger DA, Rafi MA, et al. Krabbe disease: genetic aspects and progress toward therapy. Mol Genet Metab 2000;70(1):1–9.

187.Willard HF, Riordan JR. Assignment of the gene for myelin proteolipid protein to the X chromosome: implications for X-linked myelin disorders. Science 1985;230:940–942.

188.Winkelman AC, Gray LG. Paralysis of down-gazed in familial progressive encephalopathy. Frank B. Walsh Society Annual Meeting, Salt Lake City, Utah, February 1991.

189.Wisniewski KE, Kida E, et al. Variability in the clinical and pathological findings in the neuronal ceroid lipofuscinoses: review of data and observations. Am J Med Genet 1992;42(4):525–532.

190.Wisniewski KE, Kida E, Patxot OF, et al. Neuronal ceroid lipofuscinoses: research update. Neurol Sci 2000;21(3):S49–S56.

191.Wolfe LS, Palo J, Santavouri P, et al. Urinary sediment dolichols in the diagnosis of neuronal ceroid-lipofuscinosis. Ann Neurol 1986; 19:270–274.

192.Woodward K, Malcolm S. Proteolipid protein gene: Pelizaeus– Merzbacher disease in humans and neurodegeneration in mice. Trends Genet 1999;15(4):125–128.

193.Wulff CH. Subacute sclerosing panencephalitis: serial electroencephalographic studies. J Neurol Neurosurg Psychiatry 1982;45: 418.

194.Yamanaka R, Nomura Y, Segawa M, et al. MELAS, myoclonus, ataxia and deficiencies of complexes I and IV in muscle mitochondria. Acta Paediatr Jpn 1987;29:761.

195.Zafeiriou DI, Kontopoulos EE, et al. Neurophysiology and MRI in late-infantile metachromatic leukodystrophy. Pediatr Neurol 1999; 21(5):843–846.

196.Zagami AS, Lethlean AK. Chorioretinitis as a possible very early manifestation of subacute sclerosing panencephalitis. Aust NZ J Med 1991;21:350–352.

197.Zhang X, Rafi MA, DeGala G, Wenger DA. The mechanism for a 33-nucleotide insertion in an RNA causing sphingolipid activator protein (SAP-1)-deficient metachromatic leukodystrophy. Hum Genet 1991;87:211–215.